Czech Healthcare Reforms Series 7 - Changes to Prescription Charges
From January 2012 Kc 30 per script will be payable as opposed to Kc30 per item. However, new co-payments will be introduced for drugs costing less than Kc50. ‘Supportive drugs’ such as migraine and hypertension will now be subject to a co-payment whereas they were not before. This will not affect some drugs because in each drug group there will be at least one which is exempt from co-payment. Choice is now introduced.
Medicines tax will be increased from 10% to 14%.
Christopher, CEO and founder director of Meritas International & Consulting, has spent all of his career in healthcare across three continents and is intrigued by healthcare delivery systems across the world.
or
christopher@meritas-international.com
Christopher, CEO and founder director of Meritas International & Consulting, has spent all of his career in healthcare across three continents and is intrigued by healthcare delivery systems across the world.
To discuss your consulting needs please contact Meritas International & Consulting on
christopher@meritas-international.com